News Release

BU: HPV vaccine associated with improved fertility in some women

Peer-Reviewed Publication

Boston University School of Medicine

More than 40 percent of American teens are now getting vaccinated against human papillomavirus (HPV). But, despite HPV infection being associated with reduced semen quality and lower pregnancy rates, there is still public concern about whether the HPV vaccine itself could affect future fertility.

Now, the first prospective cohort examining the relationship between HPV vaccination and fertility, led by a Boston University School of Public Health (BUSPH) researcher, has found that the vaccine can actually improve chances of conception in some women.

The study, published in the journal Paediatric and Perinatal Epidemiology, shows little overall association between HPV vaccination and the chances of conceiving for men and women -- except among women with a history of sexually transmitted infections (STIs). STIs are associated with lower fertility, but vaccinated women with an STI history had about the same chance of becoming pregnant as unvaccinated women who had never had an STI.

"Our study found no adverse effects of HPV vaccination on fertility and indicated that it may, in fact, protect fertility among individuals who have had other STIs," says BUSPH doctoral student Kathryn McInerney, the study's lead author. "Our study should reassure those who are hesitant to vaccinate due to fertility concerns."

The study used data from the Pregnancy Study Online (PRESTO), a preconception cohort of North American pregnancy planners. The ongoing study enrolled 3,483 women and 1,022 men aged 21 to 45 years who were actively trying to conceive. Couples were followed for 12 months or until pregnancy, whichever came first. At enrollment, 33.9 percent of women had been vaccinated against HPV, compared to 5.2 percent of men.

"Internationally, parents have chosen not to vaccinate their children due to concerns about the vaccine's effect on future fertility," McInerney says. "We hope this study will be useful for health providers who counsel individuals and families about HPV vaccination."


BUSPH co-authors on the study include: Elizabeth Hatch and Kenneth Rothman, professors of epidemiology; Lauren Wise, professor of epidemiology and the principal investigator of PRESTO; and doctoral student Amelia Wesselink. Other authors are Rebecca Perkins, associate professor of obstetrics and gynecology at the School of Medicine, and Ellen Mikkelsen, senior researcher at Aarhus University Hospital in Denmark.

About Boston University School of Public Health:

Boston University School of Public Health, founded in 1976, offers master's- and doctoral-level education in public health. The faculty in six departments (biostatistics; community health sciences; environmental health; epidemiology; global health; and health law, policy & management) conduct policy-changing public health research around the world, with the mission of improving the health of populations -- especially the disadvantaged, underserved, and vulnerable -- locally, nationally, and internationally.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.